List of Tables
Table 1. Global Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Acetaminophen
Table 3. Key Players of Ibuprofen
Table 4. Key Players of Other
Table 5. Global Antipyretic Medicine for Infants and Young Children Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Antipyretic Medicine for Infants and Young Children Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Antipyretic Medicine for Infants and Young Children Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Antipyretic Medicine for Infants and Young Children Market Share by Region (2019-2024)
Table 9. Global Antipyretic Medicine for Infants and Young Children Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Antipyretic Medicine for Infants and Young Children Market Share by Region (2025-2030)
Table 11. Antipyretic Medicine for Infants and Young Children Market Trends
Table 12. Antipyretic Medicine for Infants and Young Children Market Drivers
Table 13. Antipyretic Medicine for Infants and Young Children Market Challenges
Table 14. Antipyretic Medicine for Infants and Young Children Market Restraints
Table 15. Global Antipyretic Medicine for Infants and Young Children Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Antipyretic Medicine for Infants and Young Children Market Share by Players (2019-2024)
Table 17. Global Top Antipyretic Medicine for Infants and Young Children Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipyretic Medicine for Infants and Young Children as of 2023)
Table 18. Ranking of Global Top Antipyretic Medicine for Infants and Young Children Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Antipyretic Medicine for Infants and Young Children Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Antipyretic Medicine for Infants and Young Children, Headquarters and Area Served
Table 21. Global Key Players of Antipyretic Medicine for Infants and Young Children, Product and Application
Table 22. Global Key Players of Antipyretic Medicine for Infants and Young Children, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antipyretic Medicine for Infants and Young Children Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Type (2019-2024)
Table 26. Global Antipyretic Medicine for Infants and Young Children Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Type (2025-2030)
Table 28. Global Antipyretic Medicine for Infants and Young Children Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Application (2019-2024)
Table 30. Global Antipyretic Medicine for Infants and Young Children Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Antipyretic Medicine for Infants and Young Children Revenue Market Share by Application (2025-2030)
Table 32. North America Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Antipyretic Medicine for Infants and Young Children Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Antipyretic Medicine for Infants and Young Children Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Antipyretic Medicine for Infants and Young Children Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Antipyretic Medicine for Infants and Young Children Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Antipyretic Medicine for Infants and Young Children Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size by Country (2025-2030) & (US$ Million)
Table 47. Xinhua Pharmaceutical Company Details
Table 48. Xinhua Pharmaceutical Business Overview
Table 49. Xinhua Pharmaceutical Antipyretic Medicine for Infants and Young Children Product
Table 50. Xinhua Pharmaceutical Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
Table 51. Xinhua Pharmaceutical Recent Development
Table 52. IOLCP Company Details
Table 53. IOLCP Business Overview
Table 54. IOLCP Antipyretic Medicine for Infants and Young Children Product
Table 55. IOLCP Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
Table 56. IOLCP Recent Development
Table 57. Granules Biocause Company Details
Table 58. Granules Biocause Business Overview
Table 59. Granules Biocause Antipyretic Medicine for Infants and Young Children Product
Table 60. Granules Biocause Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
Table 61. Granules Biocause Recent Development
Table 62. Strides Shasun Company Details
Table 63. Strides Shasun Business Overview
Table 64. Strides Shasun Antipyretic Medicine for Infants and Young Children Product
Table 65. Strides Shasun Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
Table 66. Strides Shasun Recent Development
Table 67. Mallinckrodt Company Details
Table 68. Mallinckrodt Business Overview
Table 69. Mallinckrodt Antipyretic Medicine for Infants and Young Children Product
Table 70. Mallinckrodt Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
Table 71. Mallinckrodt Recent Development
Table 72. Farmson Company Details
Table 73. Farmson Business Overview
Table 74. Farmson Antipyretic Medicine for Infants and Young Children Product
Table 75. Farmson Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
Table 76. Farmson Recent Development
Table 77. Granules India Company Details
Table 78. Granules India Business Overview
Table 79. Granules India Antipyretic Medicine for Infants and Young Children Product
Table 80. Granules India Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
Table 81. Granules India Recent Development
Table 82. SKPL Company Details
Table 83. SKPL Business Overview
Table 84. SKPL Antipyretic Medicine for Infants and Young Children Product
Table 85. SKPL Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
Table 86. SKPL Recent Development
Table 87. Atabay Company Details
Table 88. Atabay Business Overview
Table 89. Atabay Antipyretic Medicine for Infants and Young Children Product
Table 90. Atabay Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
Table 91. Atabay Recent Development
Table 92. Temad Company Details
Table 93. Temad Business Overview
Table 94. Temad Antipyretic Medicine for Infants and Young Children Product
Table 95. Temad Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
Table 96. Temad Recent Development
Table 97. Anqiu Lu'an Company Details
Table 98. Anqiu Lu'an Business Overview
Table 99. Anqiu Lu'an Antipyretic Medicine for Infants and Young Children Product
Table 100. Anqiu Lu'an Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
Table 101. Anqiu Lu'an Recent Development
Table 102. Zhejiang Kangle Company Details
Table 103. Zhejiang Kangle Business Overview
Table 104. Zhejiang Kangle Antipyretic Medicine for Infants and Young Children Product
Table 105. Zhejiang Kangle Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
Table 106. Zhejiang Kangle Recent Development
Table 107. Hebei Jiheng Company Details
Table 108. Hebei Jiheng Business Overview
Table 109. Hebei Jiheng Antipyretic Medicine for Infants and Young Children Product
Table 110. Hebei Jiheng Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
Table 111. Hebei Jiheng Recent Development
Table 112. Novacyl Company Details
Table 113. Novacyl Business Overview
Table 114. Novacyl Antipyretic Medicine for Infants and Young Children Product
Table 115. Novacyl Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
Table 116. Novacyl Recent Development
Table 117. Anhui Fubore Company Details
Table 118. Anhui Fubore Business Overview
Table 119. Anhui Fubore Antipyretic Medicine for Infants and Young Children Product
Table 120. Anhui Fubore Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
Table 121. Anhui Fubore Recent Development
Table 122. Anhui BBCA Likang Company Details
Table 123. Anhui BBCA Likang Business Overview
Table 124. Anhui BBCA Likang Antipyretic Medicine for Infants and Young Children Product
Table 125. Anhui BBCA Likang Revenue in Antipyretic Medicine for Infants and Young Children Business (2019-2024) & (US$ Million)
Table 126. Anhui BBCA Likang Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
Table 130. Authors List of This Report
List of Figures
Figure 1. Antipyretic Medicine for Infants and Young Children Picture
Figure 2. Global Antipyretic Medicine for Infants and Young Children Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Antipyretic Medicine for Infants and Young Children Market Share by Type: 2023 VS 2030
Figure 4. Acetaminophen Features
Figure 5. Ibuprofen Features
Figure 6. Other Features
Figure 7. Global Antipyretic Medicine for Infants and Young Children Market Size by Application (2024-2030) & (US$ Million)
Figure 8. Global Antipyretic Medicine for Infants and Young Children Market Share by Application: 2023 VS 2030
Figure 9. Online Sales Case Studies
Figure 10. Offline Sales Case Studies
Figure 11. Antipyretic Medicine for Infants and Young Children Report Years Considered
Figure 12. Global Antipyretic Medicine for Infants and Young Children Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Antipyretic Medicine for Infants and Young Children Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Antipyretic Medicine for Infants and Young Children Market Share by Region: 2023 VS 2030
Figure 15. Global Antipyretic Medicine for Infants and Young Children Market Share by Players in 2023
Figure 16. Global Top Antipyretic Medicine for Infants and Young Children Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipyretic Medicine for Infants and Young Children as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Antipyretic Medicine for Infants and Young Children Revenue in 2023
Figure 18. North America Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Antipyretic Medicine for Infants and Young Children Market Share by Country (2019-2030)
Figure 20. United States Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Antipyretic Medicine for Infants and Young Children Market Share by Country (2019-2030)
Figure 24. Germany Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Antipyretic Medicine for Infants and Young Children Market Share by Region (2019-2030)
Figure 32. China Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Antipyretic Medicine for Infants and Young Children Market Share by Country (2019-2030)
Figure 40. Mexico Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Antipyretic Medicine for Infants and Young Children Market Share by Country (2019-2030)
Figure 44. Turkey Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. UAE Antipyretic Medicine for Infants and Young Children Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Xinhua Pharmaceutical Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
Figure 48. IOLCP Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
Figure 49. Granules Biocause Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
Figure 50. Strides Shasun Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
Figure 51. Mallinckrodt Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
Figure 52. Farmson Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
Figure 53. Granules India Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
Figure 54. SKPL Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
Figure 55. Atabay Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
Figure 56. Temad Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
Figure 57. Anqiu Lu'an Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
Figure 58. Zhejiang Kangle Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
Figure 59. Hebei Jiheng Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
Figure 60. Novacyl Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
Figure 61. Anhui Fubore Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
Figure 62. Anhui BBCA Likang Revenue Growth Rate in Antipyretic Medicine for Infants and Young Children Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed